stopmultiplesclerosis.eu
Open in
urlscan Pro
82.223.97.148
Public Scan
URL:
https://stopmultiplesclerosis.eu/
Submission: On May 17 via api from US — Scanned from ES
Submission: On May 17 via api from US — Scanned from ES
Form analysis
2 forms found in the DOMPOST https://stopmultiplesclerosis.eu/
<form class="w-form layout_hor for_cform us_form_1" autocomplete="off" action="https://stopmultiplesclerosis.eu/" method="post">
<div class="w-form-h">
<div class="w-form-row for_text required">
<div class="w-form-row-field">
<input aria-label="Name" type="text" name="us_form_1_text_1" value="" placeholder="Name *" data-required="true" aria-required="true">
</div>
<div class="w-form-row-state">Fill out this field</div>
</div>
<div class="w-form-row for_email required">
<div class="w-form-row-field">
<input aria-label="Email" type="email" name="us_form_1_email_1" value="" placeholder="Email *" data-required="true" aria-required="true">
</div>
<div class="w-form-row-state">Please enter a valid email address.</div>
</div>
<input type="hidden" name="action" value="us_ajax_cform">
<input type="hidden" name="post_id" value="7">
<input type="hidden" name="form_index" value="1">
<input type="hidden" name="queried_object_id" value="7">
<input type="hidden" name="queried_object_type" value="post">
<div class="w-form-row for_submit align_none">
<button class="w-btn us-btn-style_3" aria-label="Submit" type="submit">
<span class="g-preloader type_1"></span>
<span class="w-btn-label">Submit</span>
</button>
</div>
</div>
<div class="w-form-message"></div>
</form>
POST https://stopmultiplesclerosis.eu/
<form class="w-form layout_ver for_cform us_form_1" autocomplete="off" action="https://stopmultiplesclerosis.eu/" method="post">
<div class="w-form-h">
<div class="w-form-row for_text">
<div class="w-form-row-field">
<input aria-label="Nombre" type="text" name="us_form_1_text_1" value="" placeholder="Nombre">
</div>
<div class="w-form-row-state">Fill out this field</div>
</div>
<div class="w-form-row for_text required">
<div class="w-form-row-field">
<input aria-label="Phone" type="text" name="us_form_1_text_2" value="" placeholder="Phone *" data-required="true" aria-required="true">
</div>
<div class="w-form-row-state">Fill out this field</div>
</div>
<div class="w-form-row for_email">
<div class="w-form-row-field">
<input aria-label="Correo electrónico" type="email" name="us_form_1_email_1" value="" placeholder="Correo electrónico">
</div>
<div class="w-form-row-state">Please enter a valid email address.</div>
</div>
<input type="hidden" name="action" value="us_ajax_cform">
<input type="hidden" name="post_id" value="10">
<input type="hidden" name="form_index" value="1">
<input type="hidden" name="queried_object_id" value="7">
<input type="hidden" name="queried_object_type" value="post">
<div class="w-form-row for_submit align_none">
<button class="w-btn icon_atleft us-btn-style_1" aria-label="Submit" type="submit">
<span class="g-preloader type_1"></span>
<i class="fas fa-envelope"></i> <span class="w-btn-label">Submit</span>
</button>
</div>
</div>
<div class="w-form-message"></div>
</form>
Text Content
* Home * Multiple Sclesoris * About Multiple Sclerosis * Types of Multiple Sclerosis * Symptoms of multiple sclerosis * Immutol * The project * News and Press * Calendar * ADEMTO * Blog * Contact * * * INNOVATIVE THERAPIES TO COMBAT MULTIPLE SCLEROSIS HARNESSING THE POWER OF ANTIGEN-SPECIFIC DENDRITIC CELLS FOR IMMUNE REGULATION Meet the Projet 1 PEOPLE WITH MULTIPLE SCLEROSIS IN SPAIN 1 PEOPLE SUFFERING FROM THIS DISEASE IN EUROPE 1 PEOPLE WITH MULTIPLE SCLEROSIS IN THE WORLD WHAT IS MULTIPLE SCLEROSIS? Multiple sclerosis is an autoimmune disease in which the immune system attacks myelin, the substance that covers nerve fibers in the brain and spinal cord. Myelin acts as an insulator, allowing nerve impulses to travel quickly along nerve fibers. When myelin is damaged, nerve impulses can be interrupted or stopped, leading to a wide range of neurological symptoms. In Europe only there are, around 500,000 people suffering from this disease, which is often diagnosed in individuals (mostly women) aged 20 to 40. We’re in dire need of novel treatments for Multiple Sclerosis that not only effectively address the root cause of the disease but also offer safety and efficiency. These therapies should aim to minimize treatment duration and frequency while mitigating potential side effects. MULTIPLE SCLEROSIS IS HETEROGENEOUS It is also called “the disease of 1000 faces.” NEUROLOGICAL. Nerve impulse transmission fails VARIOUS SYMPTOMS. Mobility, sensory, vision, fatigue, etc. problems. UNPREDICTABLE Its course cannot be predicted with certainty and may worsen over time. THERE IS NO KNOWN CAUSE OR CURE. Research and your support are essential IT APPEARS IN YOUNG ADULTS. First cause of non-traumatic disability in this group. BUT… WHY DOES MULTIPLE SCLEROSIS OCCUR? The cause of MS is unknown, but researchers believe it results from a combination of genetic and environmental factors that cause our immune system cells to attack the nervous system. The immune system’s mission is to defend our bodies against external threats such as viruses and bacteria. However, in autoimmune diseases like MS, our defenses attack the body itself, making the immune system the aggressor: it attacks us instead of protecting us. Although, as already explained, the cause may be a combination of environmental and genetic factors, MS is not considered a hereditary disease. However, there is a genetic susceptibility, meaning we are at a higher risk of developing MS if a family member has the disease. OUR GOAL WITH THIS PROJECT TO TAKE TOLEROGENIC DENDRITIC CELL-BASED THERAPIES TO THE NEXT LEVEL TO FAST-TRACK CELL DEVELOPMENT OF A 2ND GENERATION VITD3DC PRODUCT FOR CLINICAL APPLICATION LATEST NEWS AND PRESS RELEASES News and press ADEMTO PRESENTS TODAY THE III NATIONAL HOPE AWARD News and press THE UNITED KINGDOM AMBASSADOR TO SPAIN VISITED ADEMTO SIGN UP TO OUR NEWSLETTER AND BE THE FIRST TO KNOW OUR PROGRESS AND RESULTS Fill out this field Please enter a valid email address. Submit * Home * Multiple Sclesoris * Immutol * The project * News and Press * Calendar * ADEMTO * Blog * Contact * * CONTACT US Fill out this field Fill out this field Please enter a valid email address. Submit FOLLOW US Facebook Twitter Instagram YouTube * Privacy Policy * Cookies Policy * Legal Notice Funded by the European Union under Grant Agreement No. 101080562. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them. Menu